drugset / Trial / NCT06683352

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

NCT06683352

Phase 1/2 Completed 1353 enrolled BioNTech SE Pfizer · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.

Timeline

Start
2024-11-11
Primary completion
2025-07-15
Completion
2025-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Elasomeran Messenger RNA (mRNA)
Subject Investigational Influenza Vaccine Vaccine
Comparator Licensed Influenza Vaccine 1 Vaccine
Comparator Licensed Influenza Vaccine 2 Vaccine
Subject SPUNOLEUCEL Vaccine

Indications